Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Michael L. who wrote (5922)	1/21/1999 5:51:00 PM
From: FNS	Respond to of 6136

Michael, Agph has recouped almost 1/2 the reversal...but I do agree that AGPH is still a buy. If you're going to play, best to keep a tight stop around 50...lower support is 46-47. On the other hand AGPH may just keep going to test 59 by earnings time. My gut tells me we have started a SHAKEOUT and AGPH will have one more double bottom test at 51,,,and then up. 60 is a triple top break out (IMO!). Hope for great earnings! (I have no clue, but the chart looks good.) Good luck! FNS